Omnicell reported Q3 2023 revenues of $299 million, a decrease of 14% year-over-year. GAAP net income was $6 million, or $0.12 per diluted share, while non-GAAP net income was $28 million, or $0.62 per diluted share. The company is taking actions to manage costs and align with anticipated top-line performance.
Total GAAP revenues for Q3 2023 were $299 million, down 14% from Q3 2022.
GAAP net income for Q3 2023 was $6 million, or $0.12 per diluted share, compared to $17 million, or $0.37 per diluted share, for Q3 2022.
Non-GAAP net income for Q3 2023 was $28 million, or $0.62 per diluted share, compared to $45 million, or $1.00 per diluted share, for Q3 2022.
Cash and cash equivalents as of September 30, 2023, were $447 million.
For Q4 2023, Omnicell expects total revenues between $247 million and $267 million, product revenues between $142 million and $152 million, service revenues between $105 million and $115 million, non-GAAP EBITDA between $9 million and $19 million, and non-GAAP earnings per share between $0.07 and $0.22.
Analyze how earnings announcements historically affect stock price performance